Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Marizomib

EU orphan designation number: EU/3/14/1295   
Active ingredient: Marizomib
Indication: Treatment of plasma cell myeloma
Sponsor: Richardson Associates Regulatory Affairs Ltd
Tripps Farmhouse, Lower End, Great Milton, Oxfordshire OX44 7NJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/08/2014 Orphan designation EMA/OD/035/14 (2014)5520 of 29/07/2014